| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 214.24▲ | 214.24▲ | 214.20▲ | 216.00▼ | 213.24▲ |
| MA10 | 214.24▲ | 214.29▲ | 213.56▲ | 215.02▼ | 212.41▲ |
| MA20 | 214.20▲ | 213.26▲ | 213.26▲ | 213.14▲ | 210.46▲ |
| MA50 | 214.10▲ | 214.99▼ | 215.80▼ | 210.40▲ | 197.75▲ |
| MA100 | 213.48▲ | 215.62▼ | 214.25▲ | 211.57▲ | 183.61▲ |
| MA200 | 213.03▲ | 213.56▲ | 212.12▲ | 202.49▲ | 157.28▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.004▲ | 0.240▲ | 0.317▲ | -0.155▼ | -0.229▼ |
| RSI | 54.805▲ | 53.764▲ | 49.678▼ | 52.086▲ | 55.293▲ |
| STOCH | 71.397 | 61.949 | 80.296▲ | 47.326 | 63.156 |
| WILL %R | -16.176▲ | -20.195▲ | -18.416▲ | -67.155 | -28.456 |
| CCI | 63.242 | 43.585 | 79.471 | -46.205 | 59.578 |
|
Sunday, January 25, 2026 07:31 PM
As the Q3 earnings season wraps, let’s dig into this quarter’s best and worst performers in the therapeutics industry, including Amgen (NASDAQ:AMGN) and its peers. Over the next few years, therapeutic ...
|
|
Sunday, January 25, 2026 09:26 AM
Strong tech spending in 2026 will be a tailwind for these two companies operating in fast-growing areas.
|
|
Friday, January 23, 2026 06:20 AM
Nasdaq seeks SEC approval to remove restrictions on options trading.
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 27/01/26 | 211.89 | 215.19 | 211.44 | 214.19 | 279,400 |
| 26/01/26 | 213.86 | 217.00 | 210.10 | 211.85 | 260,600 |
| 23/01/26 | 217.28 | 219.83 | 212.27 | 214.26 | 296,100 |
| 22/01/26 | 222.05 | 224.73 | 217.80 | 219.08 | 215,600 |
| 21/01/26 | 216.94 | 221.55 | 214.30 | 220.63 | 420,200 |
| 20/01/26 | 210.89 | 215.76 | 210.89 | 215.29 | 250,300 |
| 16/01/26 | 218.64 | 221.98 | 214.01 | 214.90 | 313,500 |
| 15/01/26 | 211.65 | 214.97 | 209.49 | 214.35 | 197,300 |
| 14/01/26 | 213.35 | 214.33 | 210.42 | 211.97 | 160,020 |
| 13/01/26 | 213.18 | 213.98 | 209.035 | 213.67 | 231,060 |
|
|
||||
|
|
||||
|
|